Cargando…
ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS
BACKGROUND: Gastric and esophagogastric junction adenocarcinoma are responsible for approximately 13.5% of cancer-related deaths. Given the fact that these tumors are not typically detected until they are already in the advanced stages, neoadjuvancy plays a fundamental role in improving long-term su...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Colégio Brasileiro de Cirurgia Digestiva
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735268/ https://www.ncbi.nlm.nih.gov/pubmed/35019128 http://dx.doi.org/10.1590/0102-672020210002e1616 |
_version_ | 1784628193961967616 |
---|---|
author | de CASTRO, Juliana Silveira Lima PELOSOF, Adriane Graicer de ANDRADE-CABRAL, João Guilherme Guerra SERAPHIM, Alvaro Moura TAGLIERI, Eloy COIMBRA, Felipe Jose Fernandez ZITRON, Claudia |
author_facet | de CASTRO, Juliana Silveira Lima PELOSOF, Adriane Graicer de ANDRADE-CABRAL, João Guilherme Guerra SERAPHIM, Alvaro Moura TAGLIERI, Eloy COIMBRA, Felipe Jose Fernandez ZITRON, Claudia |
author_sort | de CASTRO, Juliana Silveira Lima |
collection | PubMed |
description | BACKGROUND: Gastric and esophagogastric junction adenocarcinoma are responsible for approximately 13.5% of cancer-related deaths. Given the fact that these tumors are not typically detected until they are already in the advanced stages, neoadjuvancy plays a fundamental role in improving long-term survival. Identification of those with complete pathological response (pCR) after neoadjuvant chemotherapy (NAC) is a major challenge, with effects on organ preservation, extent of resection, and additional surgery. There is little or no information in the literature about which endoscopic signs should be evaluated after NAC, or even when such re-evaluation should occur. AIM: To describe the endoscopic aspects of patients with gastric and esophagogastric junction adenocarcinomas who underwent NAC and achieved pCR, and to determine the accuracy of esophagogastroduodenoscopy (EGD) in predicting the pCR. METHODS: A survey was conducted of the medical records of patients with these tumors who were submitted to gastrectomy after NAC, with anatomopathological result of pCR. RESULTS: Twenty-nine patients were identified who achieved pCR after NAC within the study period. Endoscopic responses were used to classify patients into two groups: G1-endoscopic findings consistent with pCR and G2-endoscopic findings not consistent with pCR. Endoscopic evaluation in G1 was present in an equal percentage (47.4%; p=0.28) in Borrmann classification II and III. In this group, the predominance was in the gastric body (57.9%; p=0.14), intestinal subtype with 42.1% (p=0.75), undifferentiated degree, 62.5% (p=0.78), Herb+ in 73.3% (p=0.68). The most significant finding, however, was that the time interval between NAC and EGD was longer for G1 than G2 (24.4 vs. 10.2 days, p=0.008). CONCLUSION: EGD after NAC seems to be a useful tool for predicting pCR, and it may be possible to use it to create a reliable response classification. In addition, the time interval between NAC and EGD appears to significantly influence the predictive power of endoscopy for pCR. |
format | Online Article Text |
id | pubmed-8735268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Colégio Brasileiro de Cirurgia Digestiva |
record_format | MEDLINE/PubMed |
spelling | pubmed-87352682022-01-21 ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS de CASTRO, Juliana Silveira Lima PELOSOF, Adriane Graicer de ANDRADE-CABRAL, João Guilherme Guerra SERAPHIM, Alvaro Moura TAGLIERI, Eloy COIMBRA, Felipe Jose Fernandez ZITRON, Claudia Arq Bras Cir Dig Original Article BACKGROUND: Gastric and esophagogastric junction adenocarcinoma are responsible for approximately 13.5% of cancer-related deaths. Given the fact that these tumors are not typically detected until they are already in the advanced stages, neoadjuvancy plays a fundamental role in improving long-term survival. Identification of those with complete pathological response (pCR) after neoadjuvant chemotherapy (NAC) is a major challenge, with effects on organ preservation, extent of resection, and additional surgery. There is little or no information in the literature about which endoscopic signs should be evaluated after NAC, or even when such re-evaluation should occur. AIM: To describe the endoscopic aspects of patients with gastric and esophagogastric junction adenocarcinomas who underwent NAC and achieved pCR, and to determine the accuracy of esophagogastroduodenoscopy (EGD) in predicting the pCR. METHODS: A survey was conducted of the medical records of patients with these tumors who were submitted to gastrectomy after NAC, with anatomopathological result of pCR. RESULTS: Twenty-nine patients were identified who achieved pCR after NAC within the study period. Endoscopic responses were used to classify patients into two groups: G1-endoscopic findings consistent with pCR and G2-endoscopic findings not consistent with pCR. Endoscopic evaluation in G1 was present in an equal percentage (47.4%; p=0.28) in Borrmann classification II and III. In this group, the predominance was in the gastric body (57.9%; p=0.14), intestinal subtype with 42.1% (p=0.75), undifferentiated degree, 62.5% (p=0.78), Herb+ in 73.3% (p=0.68). The most significant finding, however, was that the time interval between NAC and EGD was longer for G1 than G2 (24.4 vs. 10.2 days, p=0.008). CONCLUSION: EGD after NAC seems to be a useful tool for predicting pCR, and it may be possible to use it to create a reliable response classification. In addition, the time interval between NAC and EGD appears to significantly influence the predictive power of endoscopy for pCR. Colégio Brasileiro de Cirurgia Digestiva 2021-12-17 /pmc/articles/PMC8735268/ /pubmed/35019128 http://dx.doi.org/10.1590/0102-672020210002e1616 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License |
spellingShingle | Original Article de CASTRO, Juliana Silveira Lima PELOSOF, Adriane Graicer de ANDRADE-CABRAL, João Guilherme Guerra SERAPHIM, Alvaro Moura TAGLIERI, Eloy COIMBRA, Felipe Jose Fernandez ZITRON, Claudia ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS |
title | ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS |
title_full | ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS |
title_fullStr | ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS |
title_full_unstemmed | ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS |
title_short | ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS |
title_sort | endoscopic characteristics of patients with complete pathological response after neoadjuvant chemotherapy for gastric and esophagogastric junction adenocarcinomas |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735268/ https://www.ncbi.nlm.nih.gov/pubmed/35019128 http://dx.doi.org/10.1590/0102-672020210002e1616 |
work_keys_str_mv | AT decastrojulianasilveiralima endoscopiccharacteristicsofpatientswithcompletepathologicalresponseafterneoadjuvantchemotherapyforgastricandesophagogastricjunctionadenocarcinomas AT pelosofadrianegraicer endoscopiccharacteristicsofpatientswithcompletepathologicalresponseafterneoadjuvantchemotherapyforgastricandesophagogastricjunctionadenocarcinomas AT deandradecabraljoaoguilhermeguerra endoscopiccharacteristicsofpatientswithcompletepathologicalresponseafterneoadjuvantchemotherapyforgastricandesophagogastricjunctionadenocarcinomas AT seraphimalvaromoura endoscopiccharacteristicsofpatientswithcompletepathologicalresponseafterneoadjuvantchemotherapyforgastricandesophagogastricjunctionadenocarcinomas AT taglierieloy endoscopiccharacteristicsofpatientswithcompletepathologicalresponseafterneoadjuvantchemotherapyforgastricandesophagogastricjunctionadenocarcinomas AT coimbrafelipejosefernandez endoscopiccharacteristicsofpatientswithcompletepathologicalresponseafterneoadjuvantchemotherapyforgastricandesophagogastricjunctionadenocarcinomas AT zitronclaudia endoscopiccharacteristicsofpatientswithcompletepathologicalresponseafterneoadjuvantchemotherapyforgastricandesophagogastricjunctionadenocarcinomas |